Just how many overweight or obese Americans are receiving treatment with GLP-1s? The past six years have seen a staggering ...

Emily J. Kirby, MD and the team at Kalos Medical Spa are now offering ShapeScale, a 3D body scanner that tracks weight loss ...

Research even suggests it can change users' sense of smell, and other common side effects include diarrhoea, nausea, 'sulphur ...

The average representation of GLP-1 drugs used for weight loss in total annual claims was 10.5% for 2025, an increase over ...

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights ...

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

The supply of GLP-1 drugs like Ozempic has been increasing, but they’re still expensive for most patients. Here are answers ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being treated for diabetes and obesity.

The nation's plastic surgeons report their practices are busier than ever as patients want to plump facial features affected by weight loss.

Ozempic, a GLP-1 drug, has been a game-changer for many, including the author, allowing them to enjoy their pregnancy without ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy.